Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid Tumors

This study has been completed.
Information provided by (Responsible Party):
Galectin Therapeutics Inc. Identifier:
First received: February 14, 2003
Last updated: March 9, 2012
Last verified: March 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2006
  Primary Completion Date: April 2005 (Final data collection date for primary outcome measure)